Blue Trust Inc
IRWD icon

Blue Trust Inc’s Ironwood Pharmaceuticals IRWD Stock Holding History

Blue Trust Inc’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$135 Hold
34
– – ﹤0.01% 2405
2026
Q2 		$143 Hold
34
– – ﹤0.01% 2402
2026
Q1 		$119 Hold
34
– – ﹤0.01% 2445
2025
Q4 		$115 Hold
34
– – ﹤0.01% 2497
2025
Q3 		$45 Hold
34
– – ﹤0.01% 2549
2025
Q2 		$24 Hold
34
– – ﹤0.01% 2435
2025
Q1 		$50 Buy
+34
New +$81 ﹤0.01% 2454
2023
Q2 		– Sell
-2,264
Closed -$28K – 2282
2023
Q1 		$28K Sell
2,264
-2,594
-53% -$29.1K ﹤0.01% 1254
2022
Q4 		$50K Buy
4,858
+4,832
+18,585% +$54.8K ﹤0.01% 917
2022
Q3 		$0 Hold
26
– – ﹤0.01% 2205
2022
Q2 		$0 Buy
+26
New +$306 ﹤0.01% 1943

Other funds holding IRWD

CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Blue Trust Inc's IRWD Position: Q3 2026 in Review

Blue Trust Inc held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2026 at 34 shares worth $135. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Blue Trust Inc first reported a position in IRWD in Q2 2022 and has held it in 11 quarters since. The position peaked at $50K in Q4 2022. 21 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Blue Trust Inc held 34 shares of Ironwood Pharmaceuticals worth $135 as of Q3 2026.
  • Blue Trust Inc left its Ironwood Pharmaceuticals share count unchanged in Q3 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #2405 holding.
  • Blue Trust Inc first reported a position in Ironwood Pharmaceuticals in Q2 2022 and has held it in 11 quarters since.
  • Blue Trust Inc's Ironwood Pharmaceuticals position peaked at $50K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.